UK probes mega AstraZeneca deal for US biotech firm

Health News

AstraZeneca

Britain’s competition watchdog on Tuesday said it was investigating the planned purchase of US biotech company Alexion by COVID vaccine-maker AstraZeneca in a deal worth $39 billion.

In a brief statement, the Competition and Markets Authority said it was looking at whether the deal would “result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services”.

Source: Read Full Article

Related posts:
  1. In sickness and wealth—how UK tests for coronavirus
  2. Major COVID-19 vaccine trial resumes in UK after safety review
  3. COVID-19 Vaccine AZD1222 Clinical Trial Resumed in Japan, Follows Restart of Trials in the UK, Brazil, South Africa and India
  4. 15-minute coronavirus antigen tests to be shipped from China to the UK
  5. Johnson rules out tougher Christmas virus curbs for UK